A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples
International Journal of Hematology · 2025-02 · 121 (2) · 151-160
DOI: 10.1007/s12185-024-03883-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hematology, online erschienen am 05.12.2024. Verfasst von Naruto Shimonishi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan. Hauptthemen laut MEDLINE: Hemophilia A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: This work was partly supported by a research grant from SEKISUI MEDICAL..
Abstract (Originalsprache)
INTRODUCTION: Prolonged activated partial thromboplastin time (aPTT) in plasma samples requires quick and accurate differential diagnosis. We developed two methods using clot waveform analysis (CWA) for plasma samples with prolonged aPTT, particularly for factor (F)VIII deficiency. One method estimates FVIII activity (FVIII:C) using CWA without measuring FVIII:C by template matching. The other utilizes CWA in the mixing test to quickly differentiate FVIII deficiency (FD), FVIII inhibitor (Inh), and lupus anticoagulant (LA). AIM: To establish a more accurate system for differential diagnosis of aPTT prolongation, including FIX deficiency, by combining a CWA-based mixing test and template matching. METHODS: Samples with FD (n = 96), LA (n = 19), and Inh (n = 28) were incubated with normal plasma. FD, LA, and Inh were differentiated using a mixing test, followed by CWA-based template matching. RESULTS: In the mixing test, sensitivity for FD, Inh, and LA was 100%, 93%, and 100%, and specificity was 96%, 100%, and 100%. Samples with FIX inhibitor (> 0.6 BU/mL) were differentiated as the inhibitor sample. In template matching, almost all severe hemophilia A and B were judged as the respective severe types. CONCLUSION: This novel CWA-based measurement system could aid in differential diagnosis of prolonged aPTT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
- The Course of Thrombosis and Hemostasis Molecular Pathology, Nara Medical University, Kashihara, Nara, Japan.
- Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan. ogiwarak@naramed-u.ac.jp.
- SEKISUI MEDICAL CO., LTD., Tokyo, Japan.
Förderung
- This work was partly supported by a research grant from SEKISUI MEDICAL.
Zitieren
APA
Shimonishi, N., Ogiwara, K., Onishi, K., Kawabe, T., Nishio, T., & Nogami, K. (2025). A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples. International Journal of Hematology, 121(2), 151-160. https://doi.org/10.1007/s12185-024-03883-0
Vancouver
Shimonishi N, Ogiwara K, Onishi K, Kawabe T, Nishio T, Nogami K. A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples. International Journal of Hematology. 2025;121(2):151-160. doi:10.1007/s12185-024-03883-0
BibTeX
@article{Shimonishi2025,
author = {Shimonishi, Naruto and Ogiwara, Kenichi and Onishi, Kengo and Kawabe, Toshiki and Nishio, Tomohisa and Nogami, Keiji},
title = {A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples},
journal = {International Journal of Hematology},
year = {2025},
volume = {121},
number = {2},
pages = {151--160},
doi = {10.1007/s12185-024-03883-0}
}
EUVIMED